藥物晶型研究_第1頁
藥物晶型研究_第2頁
藥物晶型研究_第3頁
藥物晶型研究_第4頁
藥物晶型研究_第5頁
已閱讀5頁,還剩22頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領

文檔簡介

1、藥物晶型研究提綱什么是晶體,多晶型?多晶型研究對藥物開發(fā)的重要性如何篩選和選擇藥物的新晶型多晶型的主要分析手段晶型篩選實驗的經(jīng)驗分享-溶劑選擇2022/7/31Crystal A solid material whose constituent atoms,molecules,or ions are arranged in an orderly repeating pattern extending in all three spatial dimensions.Pharmaceutical crystals Most drugs are developed as crystallineSta

2、bilityProcessabilityIP protection 什么是晶體?2022/7/31什么是多晶型? Polymorphism is the ability of a solid material to exist in more than one form or crystal structure. Polymorphs Sold phaseSame chemical compositionDifferent molecular arrangements In practice, we are interested in all the crystalline and amorp

3、hous phases for a chemical/pharmaceutical2022/7/312022/7/31多晶型研究對藥物開發(fā)的重要性2022/7/31藥物多晶型研究的重要性2022/7/312022/7/312022/7/31如何篩選和選擇藥物的新晶型2022/7/312022/7/31晶型的化學和物理分析手段2022/7/312022/7/312022/7/31Experience sharing on polymorph screening solvent selection2022/7/31The purpose of polymorph screeningFor Inno

4、vator companies - select the optimal solid-state of API for development -study relevant polymorphs for IP protectionFor CRO companies based on the customers needs - to identify as many new polymorphs (include solvate / hydrate) and amorphous form as possible - or to find the most stable form 2022/7/

5、31The method of polymorph screeningcrystallizationcrystallization from solution (slurry, anti-solvent precipitation , Solvent-thermal heating/coolingSlow/fast precipitation from saturated solutions)recrystallization from a neat compound (thermal heating/cooling, grinding , and high pressure )2022/7/

6、31polymorph screening crystallization from solutiondegree of supersaturation and Temperature are considered as the driving force of crystallisation diverse solvents result in the discovery of more polymorphs2022/7/31crystallization from solution Solvent selectionSlurryAnti-solvent precipitation Solv

7、ent-thermal heating/cooling experiments Slow/fast precipitation from saturated solutions method SolventVisual solubility (mg/mL)MeOHEtOHIPA1-ButanolACNMEKMIBKEtOAciPrOAcMTBE2-MeTHFDMFNMPDMSOCH2Cl2Toluene1,4-DioxaneHeptaneTHFAcetoneWater2022/7/31crystallization from solution rational experimental des

8、ignLimited resource How to find as many new polymorphs and amorphous form as possible API properties different solubility in the solvent poor solubility or good solubility Solvent properties Polarity-different sort of solvents (alcohols, ethers, ester etc.) Boiling point Freezing point Toxicity misc

9、ibility ?2022/7/31Slurry solvent selectionMake sure the sample is suspension solvent/mixed solvents solubility is poor2022/7/31Anti-solvent precipitation solvent selection Prepare solvent good solubilityAnti-solvent selectionPoor solubilitypolaritymiscibility miscibility Water DMF Heptane ACN 1,4-Di

10、oxane MTBE DMSO2022/7/31Solvent-thermal heating/cooling experimentschange temperature supersaturation good solubility Solvent selection solubility varies with the temperature freezing point of the solvent 2022/7/31Slow/fast precipitation from saturated solutions methodEvaporate the solvent supersaturationSlow/fast rate of crystallization Solvent selection low boiling point solventboiling pointDMF 152.8 CDMSO189 CNMP202 C2022/7/31SummarySolvent selectionkey point of the met

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
  • 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
  • 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論